Banco Bilbao Vizcaya Argentaria S.A. Reduces Position in CVS Health Co. (NYSE:CVS)

Banco Bilbao Vizcaya Argentaria S.A. reduced its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 9.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 300,319 shares of the pharmacy operator's stock after selling 31,293 shares during the period. Banco Bilbao Vizcaya Argentaria S.A.'s holdings in CVS Health were worth $13,443,000 at the end of the most recent reporting period.

Other hedge funds also recently made changes to their positions in the company. Ridgewood Investments LLC raised its position in shares of CVS Health by 255.7% during the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 450 shares during the period. Stonebridge Financial Group LLC purchased a new stake in shares of CVS Health during the fourth quarter worth about $28,000. Hopwood Financial Services Inc. bought a new stake in CVS Health during the 4th quarter valued at approximately $29,000. Financial Perspectives Inc lifted its holdings in CVS Health by 137.5% in the 4th quarter. Financial Perspectives Inc now owns 805 shares of the pharmacy operator's stock worth $36,000 after purchasing an additional 466 shares in the last quarter. Finally, MidAtlantic Capital Management Inc. grew its holdings in CVS Health by 112.1% during the 4th quarter. MidAtlantic Capital Management Inc. now owns 827 shares of the pharmacy operator's stock valued at $37,000 after buying an additional 437 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the company's stock in a transaction on Tuesday, February 18th. The stock was acquired at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now directly owns 39,356 shares in the company, valued at approximately $2,625,045.20. The trade was a 320.65 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. 1.22% of the stock is currently owned by corporate insiders.

CVS Health Trading Up 0.1 %

CVS Health stock traded up $0.07 during trading on Tuesday, reaching $65.00. 7,387,913 shares of the company were exchanged, compared to its average volume of 11,815,064. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. The stock's 50 day simple moving average is $66.45 and its two-hundred day simple moving average is $58.75. The company has a market capitalization of $81.95 billion, a P/E ratio of 17.76, a PEG ratio of 0.98 and a beta of 0.57. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $71.45.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, equities research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.09%. The ex-dividend date of this dividend is Tuesday, April 22nd. CVS Health's payout ratio is 72.68%.

Wall Street Analyst Weigh In

Several research analysts have commented on CVS shares. UBS Group dropped their price objective on shares of CVS Health from $62.00 to $59.00 and set a "neutral" rating for the company in a report on Tuesday, February 11th. Wolfe Research boosted their price target on CVS Health from 67.00 to 70.00 and gave the company an "overweight" rating in a research note on Tuesday, February 11th. Wells Fargo & Company raised their target price on shares of CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Edward Jones raised CVS Health from a "hold" rating to a "buy" rating in a research report on Thursday, January 30th. Finally, Leerink Partners raised CVS Health from a "market perform" rating to an "outperform" rating and boosted their price objective for the company from $55.00 to $75.00 in a report on Thursday, February 13th. Four analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $71.83.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.